According to reports, he consumed two 50mg tablets of Sildenafil. Sildenafil is sold under the brand name Viagra.  Wikimedia Commons
MedBound Blog

Nagpur: Man Dies After Taking Two Viagra Pills While Drinking Alcohol

A 41-year-old man died after taking two Viagra pills while drinking alcohol. The man did not have any significant medical or surgical history.

Author : Dr. Amey Patil

Another case of death due to performance-enhancing pills has surfaced from Nagpur in Maharashtra.

A 41-year-old man died after taking two Viagra pills while drinking alcohol. The man did not have any significant medical or surgical history.

The man had met a female friend at a hotel. According to reports, he consumed two 50mg tablets of Sildenafil. Sildenafil is sold under the brand name Viagra.

He started to feel uneasy and vomited the next morning. The female friend urged him to seek some medical treatment. However, he ignored it and claimed that this was not the first time something like this has happened.

The consumption of Viagra along with alcohol while having pre-existing high-blood pressure is concluded as the cause of death.

However, his symptoms worsened as time passed by. He had to be rushed to the hospital where he was declared dead. He had suffered a cerebrovascular hemorrhage in which the oxygen supply to the brain is reduced. The post-mortem reports revealed that there was around 300 grams of clotted blood.

The consumption of Viagra along with alcohol while having pre-existing high-blood pressure is concluded as the cause of death.

Such pills are usually associated with heart attacks. Researchers believe these pills can potentially cause dangerous blood clots in men. They can also lead to the constriction of arteries.

Vadodara Steroid and Hormone Drug Racket: Shop Owner Arrested and Illegal Injectables Seized

Ohio State OB-GYN Chair Received Thousands in Payments From Jeffrey Epstein Firm

Afghanistan Bans Pakistani Medicine Imports: Severe Shortages and Price Spikes Hit Pharmacies

Supreme Court Reviews PIL to Exclude Doctors from Consumer Protection Act

AstraZeneca Pharma India Secures CDSCO Nod for Expanded Use of Durvalumab in Cancer Treatment